Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis.

Schorpion A, Shenin M, Neubauer R, Derk CT.

BMC Rheumatol. 2018 May 15;2:13. doi: 10.1186/s41927-018-0021-z. eCollection 2018.

2.

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.

Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD.

J Rheumatol. 2019 Feb;46(2):176-183. doi: 10.3899/jrheum.180018. Epub 2018 Oct 1.

PMID:
30275260
3.

Mortality and survival in systemic sclerosis: a review of recent literature.

Poudel DR, Derk CT.

Curr Opin Rheumatol. 2018 Nov;30(6):588-593. doi: 10.1097/BOR.0000000000000551. Review.

PMID:
30148801
4.

Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management.

Hosoya H, Derk CT.

Biomed Res Int. 2018 Jun 4;2018:6812082. doi: 10.1155/2018/6812082. eCollection 2018.

5.

Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.

Ram Poudel D, George M, Dhital R, Karmacharya P, Sandorfi N, Derk CT.

Rheumatology (Oxford). 2018 Sep 1;57(9):1611-1622. doi: 10.1093/rheumatology/key150.

PMID:
29868788
6.

Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.

Gourh P, Remmers EF, Boyden SE, Alexander T, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA Jr, Steen VD, Ramos PS, Silver RM, Korman B, Varga J, Schiopu E, Khanna D, Hsu V, Gordon JK, Saketkoo LA, Gladue H, Kron B, Criswell LA, Derk CT, Bridges SL Jr, Shanmugam VK, Kolstad KD, Chung L, Jan R, Bernstein EJ, Goldberg A, Trojanowski M, Kafaja S, Maksimowicz-McKinnon KM, Mullikin JC, Adeyemo A, Rotimi C, Boin F, Kastner DL, Wigley FM.

Arthritis Rheumatol. 2018 Oct;70(10):1654-1660. doi: 10.1002/art.40541. Epub 2018 Aug 29.

7.

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.

Morgan ND, Shah AA, Mayes MD, Domsic RT, Medsger TA Jr, Steen VD, Varga J, Carns M, Ramos PS, Silver RM, Schiopu E, Khanna D, Hsu V, Gordon JK, Gladue H, Saketkoo LA, Criswell LA, Derk CT, Trojanowski MA, Shanmugam VK, Chung L, Valenzuela A, Jan R, Goldberg A, Remmers EF, Kastner DL, Wigley FM, Gourh P, Boin F.

Medicine (Baltimore). 2017 Dec;96(51):e8980. doi: 10.1097/MD.0000000000008980.

8.

Determinants of mortality in systemic sclerosis: a focused review.

Poudel DR, Jayakumar D, Danve A, Sehra ST, Derk CT.

Rheumatol Int. 2018 Oct;38(10):1847-1858. doi: 10.1007/s00296-017-3826-y. Epub 2017 Nov 7. Review.

PMID:
29116439
9.

Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.

Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):106-113. Epub 2016 Nov 10.

PMID:
27908301
10.

Ulcers of the Ventral Aspect of Fingers.

Grewal SK, Derk CT, Rosenbach M.

JAMA Dermatol. 2016 Oct 1;152(10):1157-1158. doi: 10.1001/jamadermatol.2016.2748. No abstract available.

PMID:
27580022
11.

Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.

Sehra ST, Kelly A, Baker JF, Derk CT.

Clin Rheumatol. 2016 Jun;35(6):1631-5. doi: 10.1007/s10067-016-3245-6. Epub 2016 Apr 7.

PMID:
27056049
12.

Diffuse cutaneous mucinosis in dermatomyositis: a case report and review of the literature.

Perel-Winkler AC, Derk CT.

Case Rep Dermatol Med. 2014;2014:938414. doi: 10.1155/2014/938414. Epub 2014 Nov 18.

13.

Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction.

Mecoli C, Purohit S, Sandorfi N, Derk CT.

J Rheumatol. 2014 Oct;41(10):2049-54. doi: 10.3899/jrheum.131547. Epub 2014 Aug 15.

PMID:
25128517
14.

Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas' disease: promising yet limited in clinical utility.

Abraham M, Derk CT.

Rheumatol Int. 2015 Jan;35(1):27-33. doi: 10.1007/s00296-014-3058-3. Epub 2014 Jun 7. Review.

PMID:
24906575
15.

Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.

Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, Silver R, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Alkassab F, Steen VD.

Semin Arthritis Rheum. 2014 Aug;44(1):55-62. doi: 10.1016/j.semarthrit.2014.03.002. Epub 2014 Mar 5.

PMID:
24709277
16.

Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA, Airo P, Carreira PE, Foti R, Granel B, Berezne A, Cabane J, Ingegnoli F, Rosato E, Caramaschi P, Hesselstrand R, Walker UA, Alegre-Sancho JJ, Zarrouk V, Agard C, Riccieri V, Schiopu E, Gladue H, Steen VD, Allanore Y.

J Rheumatol. 2014 Jan;41(1):99-105. doi: 10.3899/jrheum.130386. Epub 2013 Dec 1.

PMID:
24293584
17.

Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.

Schneeberger D, Tyndall A, Kay J, Søndergaard KH, Carreira PE, Morgiel E, Deuschle K, Derk CT, Widuchowska M, Walker UA.

Rheumatology (Oxford). 2013 Mar;52(3):560-7. doi: 10.1093/rheumatology/kes315. Epub 2012 Dec 5.

PMID:
23221323
18.

Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.

Jain S, Shahane A, Derk CT.

Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):266-77. Review.

PMID:
22506881
19.

Predictors of early mortality in systemic sclerosis: a case-control study comparing early versus late mortality in systemic sclerosis.

Derk CT, Huaman G, Littlejohn J, Otieno F, Jimenez S.

Rheumatol Int. 2012 Dec;32(12):3841-4. doi: 10.1007/s00296-011-2301-4. Epub 2011 Dec 23.

PMID:
22193226
20.

Gastric antral vascular ectasia in systemic sclerosis.

Johnson J, Derk CT.

Int J Rheumatol. 2011;2011:305238. doi: 10.1155/2011/305238. Epub 2011 Nov 2.

21.

Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases.

Schulz SW, Shenin M, Mehta A, Kebede A, Fluerant M, Derk CT.

Rheumatol Int. 2012 Sep;32(9):2623-7. doi: 10.1007/s00296-011-2053-1. Epub 2011 Jul 22.

PMID:
21833518
22.

Disease-modifying drugs for systemic sclerosis: why have we not found them yet?

Derk CT.

Expert Rev Clin Immunol. 2011 Jul;7(4):399-401. doi: 10.1586/eci.11.29. No abstract available.

PMID:
21790280
23.

Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study.

Wipff J, Coriat R, Masciocchi M, Caramaschi P, Derk CT, Hachulla E, Riccieri V, Mouthon L, Krasowska D, Ananyeva LP, Kahan A, Matucci-Cerinic M, Chaussade S, Allanore Y.

Rheumatology (Oxford). 2011 Aug;50(8):1440-4. doi: 10.1093/rheumatology/ker110. Epub 2011 Mar 16.

PMID:
21415021
24.

Endothelin receptor antagonists as disease modifiers in systemic sclerosis.

Shetty N, Derk CT.

Inflamm Allergy Drug Targets. 2011 Feb;10(1):19-26. Review.

PMID:
21184655
25.

Eosinophilic fasciitis in a pediatric patient.

Loupasakis K, Derk CT.

J Clin Rheumatol. 2010 Apr;16(3):129-31. doi: 10.1097/RHU.0b013e3181d56f73.

PMID:
20375823
26.

Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors.

Ingraham KM, O'Brien MS, Shenin M, Derk CT, Steen VD.

J Rheumatol. 2010 Mar;37(3):603-7. doi: 10.3899/jrheum.090600. Epub 2010 Jan 15.

PMID:
20080908
27.

A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.

Derk CT, Grace E, Shenin M, Naik M, Schulz S, Xiong W.

Rheumatology (Oxford). 2009 Dec;48(12):1595-9. doi: 10.1093/rheumatology/kep295. Epub 2009 Oct 21.

PMID:
19846575
28.
29.

The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

Rosenbaum E, Krebs E, Cohen M, Tiliakos A, Derk CT.

Lupus. 2009 Jun;18(7):608-12. doi: 10.1177/0961203308100659. Review.

PMID:
19433460
30.

Unmet patient needs in systemic sclerosis.

Rubenzik TT, Derk CT.

J Clin Rheumatol. 2009 Apr;15(3):106-10. doi: 10.1097/RHU.0b013e31819dbe83.

PMID:
19300284
31.

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.

Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, Riemekasten G, Cozzi F, Beretta L, Derk CT, Komócsi A, Farge D, Balbir A, Riccieri V, Distler O, Chialà A, Del Papa N, Simic KP, Ghio M, Stamenkovic B, Rednic S, Host N, Pellerito R, Zegers E, Kahan A, Walker UA, Matucci-Cerinic M; EUSTAR co-authors.

Ann Rheum Dis. 2010 Jan;69(1):218-21. doi: 10.1136/ard.2008.103382.

32.

Treatment of systemic sclerosis: potential role for stem cell transplantation.

Xiong W, Derk CT.

Stem Cells Cloning. 2009 Nov 18;2:1-9. Review.

33.

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication.

De LaVega AJ, Derk CT.

Expert Opin Investig Drugs. 2009 Jan;18(1):23-9. doi: 10.1517/13543780802525100 . Review.

PMID:
19053879
34.

The use of mycophenolate mofetil for the treatment of systemic sclerosis.

Shenin M, Naik M, Derk CT.

Endocr Metab Immune Disord Drug Targets. 2008 Mar;8(1):11-4. Review.

PMID:
18393919
35.

Premenopausal osteoporosis.

Bischoff L, Derk CT.

Minerva Med. 2008 Feb;99(1):55-63. Review.

PMID:
18299696
36.

A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset.

Derk CT, Huaman G, Jimenez SA.

Br J Dermatol. 2008 May;158(5):1063-8. doi: 10.1111/j.1365-2133.2008.08452.x. Epub 2008 Feb 16.

37.

Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.

Bischoff L, Derk CT.

Int J Dermatol. 2008 Jan;47(1):29-35. doi: 10.1111/j.1365-4632.2007.03544.x. Review.

PMID:
18173597
38.

Systemic sclerosis mortality in the United States: 1999-2002 implications for patient care.

Mendoza F, Derk CT.

J Clin Rheumatol. 2007 Aug;13(4):187-92.

PMID:
17762451
39.

Associations of breast cancer development in patients with systemic sclerosis: an exploratory study.

Derk CT.

Clin Rheumatol. 2007 Oct;26(10):1615-9. Epub 2007 Feb 2.

PMID:
17332984
40.
41.
42.

Scleroderma lung disease: treatment with cyclophosphamide.

Schulz S, Bischoff L, Michel D, Derk CT.

Expert Rev Clin Immunol. 2006 Nov;2(6):849-52. doi: 10.1586/1744666X.2.6.849.

PMID:
20476972
43.

Osteoporosis in premenopause. When are screening and treatment prudent?

Derk CT.

Postgrad Med. 2006 Jun-Jul;119(1):8-15. Review.

PMID:
16913642
44.

A cohort study of cancer incidence in systemic sclerosis.

Derk CT, Rasheed M, Artlett CM, Jimenez SA.

J Rheumatol. 2006 Jun;33(6):1113-6. Epub 2006 Mar 15.

PMID:
16622904
45.

Acute myocardial infarction in systemic sclerosis patients: a case series.

Derk CT, Jimenez SA.

Clin Rheumatol. 2007 Jun;26(6):965-8. Epub 2006 Mar 7.

PMID:
16521051
46.

Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.

Jacobs-Kosmin D, Derk CT, Sandorfi N.

J Rheumatol. 2006 Mar;33(3):629-32. Epub 2006 Feb 15.

PMID:
16482642
47.

Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study.

Derk CT, Artlett CM, Jimenez SA.

Clin Rheumatol. 2006 Nov;25(6):831-4. Epub 2006 Jan 25.

PMID:
16435160
48.

Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?

Derk CT, Jimenez SA.

Autoimmun Rev. 2006 Jan;5(1):25-32. Epub 2005 Aug 19. Review.

PMID:
16338208
49.

Rheumatoid arthritis: an update.

Derk CT.

Del Med J. 2005 Feb;77(2):59-63. Review.

PMID:
15887927
50.

Increased incidence of carcinoma of the tongue in patients with systemic sclerosis.

Derk CT, Rasheed M, Spiegel JR, Jimenez SA.

J Rheumatol. 2005 Apr;32(4):637-41.

Supplemental Content

Support Center